HALO

Nicole LaBrosse

Known title: SVP, Chief Financial OfficerCIK: 0001910662

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 5, 2026

Halozyme Adds Jim Daly to Board Amid Q2 Earnings Review. Halozyme Therapeutics has appointed Jim Daly to its Board of Directors, a move that signals continued focus on governance and long-term strategy. This update arrives alongside a broader market review of the company's Q2 performance relative to other therapeutics firms. The stock is currently trading above its average analyst target price, with recent technical data showing confirmation near key support levels.

this person other insiders at HALO

Transaction History

HALO▲ Buy$0
HALO▼ Sell$255K
HALO▲ Buy$0
HALO▼ Sell$204K
HALO▲ Buy$0
HALO▼ Sell$218K
HALO▲ Buy$0
HALO▼ Sell$228K
HALO▲ Buy$0
HALO▼ Sell$578K
HALO▼ Sell$25K
HALO▼ Sell$149K
HALO▲ Buy$136K
HALO▲ Buy$14K
HALO▼ Sell$1.0M
HALO▼ Sell$509K
HALO▲ Buy$0
HALO▼ Sell$208K
HALO▲ Buy$0
HALO▼ Sell$548K
HALO▲ Buy$0
HALO▼ Sell$167K
HALO▼ Sell$160K
HALO▲ Buy$0
HALO▲ Buy$0
HALO▼ Sell$43K
HALO▼ Sell$54K
HALO▲ Buy$90K
HALO▼ Sell$216K
HALO▲ Buy$22K
HALO▲ Buy$225K
HALO▼ Sell$520K
HALO▲ Buy$225K
HALO▼ Sell$519K
HALO▲ Buy$225K
HALO▼ Sell$518K
HALO▲ Buy$0
HALO▼ Sell$99K
HALO▲ Buy$0
HALO▼ Sell$103K
HALO▲ Buy$0
HALO▼ Sell$25K
HALO▲ Buy$0
HALO▼ Sell$52K
HALO▲ Buy$0
HALO▼ Sell$124K
HALO▲ Buy$0
HALO▼ Sell$31K
HALO▲ Buy$0
HALO▼ Sell$33K
HALO▲ Buy$0
HALO▼ Sell$68K
HALO▼ Sell$249K
HALO▼ Sell$20K
HALO▲ Buy$0
HALO▼ Sell$15K
HALO▲ Buy$0
HALO▼ Sell$14K
HALO▲ Buy$0
HALO▼ Sell$17K
HALO▲ Buy$0
HALO▼ Sell$36K

We use analytics to understand how market-wall is used. No personal data is sold.